
CTOR Valuation
Citius Oncology Inc
- Overview
- Forecast
- Valuation
- Earnings
CTOR Relative Valuation
CTOR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CTOR is overvalued; if below, it's undervalued.
Historical Valuation
Citius Oncology Inc (CTOR) is now in the Fair zone, suggesting that its current forward PS ratio of 3.45 is considered Fairly compared with the five-year average of -2.21. The fair price of Citius Oncology Inc (CTOR) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:2.13
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.91
P/B
Median3y
16.88
Median5y
16.88
0.10
FCF Yield
Median3y
0.05
Median5y
0.05
Competitors Valuation Multiple
The average P/S ratio for CTOR's competitors is 1.02, providing a benchmark for relative valuation. Citius Oncology Inc Corp (CTOR) exhibits a P/S ratio of 3.80, which is 271.43% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

HSPO
Horizon Space Acquisition I Corp
12.160
USD
+0.91%

COYA
Coya Therapeutics Inc
6.670
USD
-0.74%

LTBR
Lightbridge Corp
14.760
USD
-1.27%

FSHP
Flag Ship Acquisition Corp
0
USD
0.00%

ADVM
Adverum Biotechnologies Inc
2.700
USD
+1.12%

DTSQ
DT Cloud Star Acquisition Corp
10.400
USD
-0.68%

PAVS
Paranovus Entertainment Technology Ltd
0.880
USD
-7.56%

MNOV
MediciNova Inc
1.460
USD
+17.74%

INVE
Identiv Inc
3.750
USD
0.00%

ALOT
AstroNova Inc
11.360
USD
+0.53%
FAQ

Is Citius Oncology Inc (CTOR) currently overvalued or undervalued?
Citius Oncology Inc (CTOR) is now in the Fair zone, suggesting that its current forward PS ratio of 3.45 is considered Fairly compared with the five-year average of -2.21. The fair price of Citius Oncology Inc (CTOR) is between to according to relative valuation methord.

What is Citius Oncology Inc (CTOR) fair value?

How does CTOR's valuation metrics compare to the industry average?

What is the current P/B ratio for Citius Oncology Inc (CTOR) as of Jul 26 2025?

What is the current FCF Yield for Citius Oncology Inc (CTOR) as of Jul 26 2025?

What is the current Forward P/E ratio for Citius Oncology Inc (CTOR) as of Jul 26 2025?
